Korean firm plans CDMO business
Submitted by:
Andrew Warmington
Hanmi Fine Chemical, an API manufacturing subsidiary of Hanmi Pharmaceutical, has announced plans for a
Sterling enters second investment phase
Submitted by:
Andrew Warmington
CDMO Sterling Pharma Solutions has announced what it called the next phase of a multi-year
Oxygen shortage forces stop at Hikal
Submitted by:
Andrew Warmington
Indian fine chemical and API firm Hikal has halted production of an unnamed product from
Lonza in two expansion deals
Submitted by:
Andrew Warmington
Lonza its to expand its two-year collaboration with Moderna to manufacture the drug substance for
COVID continues to cause postponements
Submitted by:
Andrew Warmington
Mack-Brooks Exhibitions has announced the postponement of the fine and speciality chemicals trade show, Chemspec
Recipharm board backs takeover bid
Submitted by:
Andrew Warmington
The board of Swedish-based CDMO Recipharm has unanimously recommended that shareholders accept a revised offer
Germany: Associations reject industry closure idea
Submitted by:
Andrew Warmington
The German Chemical Industry Association (VCI) and the German Chemical Employers' Association (BAVC) have joined
Kaneka Eurogentec to make COVID-19 vaccine candidate
Submitted by:
Andrew Warmington
Kaneka Eurogentec, an affiliate of Japan’s Kaneka based at Liège, Belgium, has signed an agreement
Croda, Novasep part of key COVID vaccines
Submitted by:
Andrew Warmington
Both Croda International and Novasep are involved in some of the vaccines nearing approval for
Lonza moves further into ADCs
Submitted by:
Andrew Warmington
Lonza has opened the first of two manufacturing suites at its main site in Visp